162 related articles for article (PubMed ID: 32894563)
21. Response to 'The association between D-dimer in COVID-19 patients and mortality remains beset of uncertainties'.
Zhang L; Yan X; Gong Y; Zhang Z
J Thromb Haemost; 2020 Aug; 18(8):2070-2071. PubMed ID: 32608062
[No Abstract] [Full Text] [Related]
22. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.
Cheng A; Hu L; Wang Y; Huang L; Zhao L; Zhang C; Liu X; Xu R; Liu F; Li J; Ye D; Wang T; Lv Y; Liu Q
Int J Antimicrob Agents; 2020 Sep; 56(3):106110. PubMed ID: 32712332
[TBL] [Abstract][Full Text] [Related]
23. TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
Crit Care; 2020 Oct; 24(1):599. PubMed ID: 33023627
[No Abstract] [Full Text] [Related]
24. [Understanding and prevention of D-dimer elevation in coronavirus disease 2019 in traditional Chinese medicine].
Wang Q; Wang C; Mei J; He L; Li J; Liu S; Chen F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):622-624. PubMed ID: 32576359
[TBL] [Abstract][Full Text] [Related]
25. A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.
Huang Y; Lyu X; Li D; Wang L; Wang Y; Zou W; Wei Y; Wu X
PLoS One; 2020; 15(11):e0242045. PubMed ID: 33166991
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
Zadow EK; Wundersitz DWT; Hughes DL; Adams MJ; Kingsley MIC; Blacklock HA; Wu SSX; Benson AC; Dutheil F; Gordon BA
Semin Thromb Hemost; 2020 Oct; 46(7):807-814. PubMed ID: 32882720
[TBL] [Abstract][Full Text] [Related]
27. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis.
Lippi G; Favaloro EJ
Thromb Haemost; 2020 May; 120(5):876-878. PubMed ID: 32246450
[No Abstract] [Full Text] [Related]
28. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
30. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
[TBL] [Abstract][Full Text] [Related]
31. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
[No Abstract] [Full Text] [Related]
32. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
[TBL] [Abstract][Full Text] [Related]
33. Response to "All these D-dimers in COVID-19".
Zhang L
J Thromb Haemost; 2020 Aug; 18(8):2076-2077. PubMed ID: 32526058
[No Abstract] [Full Text] [Related]
34. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
36. D-dimer level is associated with the severity of COVID-19.
Yu HH; Qin C; Chen M; Wang W; Tian DS
Thromb Res; 2020 Nov; 195():219-225. PubMed ID: 32777639
[TBL] [Abstract][Full Text] [Related]
37. Hemostatic abnormalities in COVID-19: A guided review.
Sathler PC
An Acad Bras Cienc; 2020; 92(4):e20200834. PubMed ID: 32844987
[TBL] [Abstract][Full Text] [Related]
38. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
Tang N; Li D; Wang X; Sun Z
J Thromb Haemost; 2020 Apr; 18(4):844-847. PubMed ID: 32073213
[TBL] [Abstract][Full Text] [Related]
39. D-dimer Triage for COVID-19.
Li C; Hu B; Zhang Z; Qin W; Zhu Z; Zhai Z; Davidson BL; Wang C
Acad Emerg Med; 2020 Jul; 27(7):612-613. PubMed ID: 32506683
[No Abstract] [Full Text] [Related]
40. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
